Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 19, 2020

View Archived Issues

Microbiome metabolites as immunotherapy adjuvants

Oxygen therapy harms lungs via lung, gut microbiome

Positive preclinical data presented for multi-target COVID-19 vaccine

T-2143, a novel HSP90-PI3K drug conjugate with promising activity in cancer models

Discovery of a novel FASN inhibitor with promising activity in model of AD

BrightGene Bio-Medical Technology identifies Gly12Cys mutant GTPase KRAS inhibitors

New PD-1/PD-L1 and/or PD-L1/CD80 interaction inhibitors patented by Betta Pharmaceuticals

Jiangsu Vcare Pharmatech discovers JAK inhibitors

Zhejiang Hisun Pharmaceutical presents new RET inhibitors

University of Queensland, Preveceutical Medical patent delta- and kappa-opioid receptor antagonists

Update on development of PGX-YBG inhalable therapeutic for COVID-19

First patient dosed in phase Ib study of ARO-HIF2 in clear cell renal cell carcinoma

Topline data presented from phase II study of elobixibat in NAFLD and NASH

FDA issues complete response letter for filgotinib for the treatment of RA

Promising interim data presented from phase II study of ERC-1671 in recurrent GBM

Phase II study of QBECO SSI in colorectal cancer approved in Israel

Evotec and Novo Nordisk collaborate to develop novel therapies for CKD

Targeting the adenosine A2A receptor may prevent osteoarthritis progression

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...